Plain-English translation of NCT07190573 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial, called HOPE, is studying head and neck cancer by collecting tumor tissue and genetic samples from patients like you. Researchers want to understand why some people respond better to treatment than others, so they can eventually personalize care and improve outcomes for future patients with head and neck cancer.
Head and neck cancer is a serious disease that affects many people worldwide, and current treatments don't work equally well for everyone. By studying the genetics and biology of individual tumors, doctors hope to develop personalized treatment plans that work better for each patient's specific cancer.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow researchers to collect tissue samples from your tumor (either new samples or existing ones from your diagnosis) and access your medical records. You may also be asked to provide blood or other tissue samples, and to share information about your cancer history, treatment, and how you're doing. The study is ongoing, so researchers will track your health outcomes over time.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
South Korea
Enrollment target
~350 participants
Started
April 2025
Primary completion
January 2030
Age range
20 Years and older
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Nayeon Choi, M.D.
Samsung Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.